The Pharmaceutical company Abbott Laboratories will pay 3.72 billion dollars for the generic business of Indian company Piramal Healthcare, Reuters reported. From Abbott have announced that the deal will become the largest producer of medicines in India. Global demand for generic medicines which are cheaper versions of expensive patented drugs manufactured by Indian companies like Ranbaxy Laboratories, Dr Reddy’s Laboratories and Cipla, with the growing aspirations of governments to reduce healthcare costs. Developing markets where generics are the main sales are the new battlefield of global pharmaceutical companies, whose sales in western markets are losing momentum. Just in the beginning of the year the company completed the deal with Solvay for buying the pharmaceutical sector and paid more than 4 billions USD for the business and distribution network all over the world. Abbott Laboratories is company realizing high investments in the years of crisis, buying companies all over the world and making large network for distribution of the products.
Continue Reading